Lesion distributions | Immunocompromised patients | Immunocompetent patients | ||||||
---|---|---|---|---|---|---|---|---|
tN | Rate (%) | 95% CI | I2 (%) | tN | Rate (%) | 95% CI | I2 (%) | |
Bilateral lung distribution | 178 | 50.0 | 36.2–64.7 | 60.4 | 157 | 30.4 | 18.6–42.1 | 57.1 |
Peripheral distribution | 78 | 62.5 | 37.9–87.1 | 79.3 | 113 | 73.5 | 50.1–97.0 | 90.3 |
Upper lung involvement | 129 | 53.8 | 34.5–73.2 | 67.1 | 115 | 40.8 | 28.2–53.4 | 48.6 |
Middle lung involvement | 129 | 20.0 | 0.00–42.8 | 87.6 | 115 | 17.1 | 4.8–29.4 | 59.9 |
Lower lung involvement | 129 | 71.8 | 55.5–88.0 | 57.7 | 115 | 78.6 | 70.6–86.5 | 11.6 |